Recent remarks from antitrust regulators suggest increased scrutiny of perceived anti-competitive and corrupt conduct that could be contributing to recent supply chain slowdowns so companies should double down on compliance efforts, say attorneys at V&E.
Pfizer CEO Albert Bourla was asked this week about Pfizer’s record of wrongdoing. On the Lex Fridman podcast, Bourla was asked about a 2009 prosecution in which Pfizer paid $2.3 billion and the Pfizer unit Pharmacia & Upjohn Company pled guilty to a felony for misbranding anti-inflammatory drug Bextra with the intent to defraud or…
Over the course of the year and even dating back to his time on the campaign trail President Biden and senior officials in his administration, including Department of Justice (DOJ).
We begin the week before Christmas by looking at one heck of a compliance failure (or perhaps series of compliance failures) which led JPMorgan Chase Bank, NA, J.P. Morgan Securities.